Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released May 5, 2022, after the close
10-Q filed May 5, 2022, 35 days after period end · 0001104659-22-056442
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $174.00K | $685.00K | $2.73M | $1.43M |
| EPS Diluted | -$0.49 | -$0.42 | -$0.73 | -$1.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR